Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 1,533,996 |
|
|||||
| News | - | ||||||
| Day High | 40.74 | Low High |
|||||
| Day Low | 39.14 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc | RARE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.49 | 3.86% | 40.14 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 39.68 | 39.14 | 40.74 | 40.14 | 38.65 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18,152 | 1,533,996 | $ 40.12 | $ 61,545,645 | - | 31.52 - 54.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:04:37 | formt | 5,387 | $ 40.14 | USD |
Ultragenyx Pharmaceutical (RARE) Options Flow Summary
Ultragenyx Pharmaceutical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.3B | 82.34M | - | 434.25M | -606.64M | -7.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ultragenyx Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RARE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.98 | 40.89 | 37.82 | 39.05 | 597,399 | 0.16 | 0.40% |
| 1 Month | 44.88 | 46.005 | 37.82 | 41.23 | 698,766 | -4.74 | -10.56% |
| 3 Months | 51.42 | 52.56 | 37.82 | 44.50 | 723,535 | -11.28 | -21.94% |
| 6 Months | 39.59 | 54.56 | 37.82 | 45.47 | 761,182 | 0.55 | 1.39% |
| 1 Year | 48.56 | 54.98 | 31.52 | 42.23 | 753,802 | -8.42 | -17.34% |
| 3 Years | 101.65 | 105.506 | 31.52 | 52.72 | 643,941 | -61.51 | -60.51% |
| 5 Years | 55.79 | 179.647 | 31.52 | 61.33 | 577,860 | -15.65 | -28.05% |
Ultragenyx Pharmaceutical Description
| Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. |
